Researchers at UC Santa Cruz have developed a novel chip-based antigen test that can provide ultrasensitive detection of SARS-CoV-2 and influenza A, the viruses that cause COVID-19 and flu, ...
Many factors have been identified as having the ability to affect the sensitivity of rapid antigen detection (RAD) tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The authors ...
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, has globally infected more than 639 million individuals and claimed ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its Simoa® technology ...
DONGGUAN, China, Sept. 9, 2024 /PRNewswire/ -- In the face of the escalating mpox outbreak, health authorities worldwide are on high alert, particularly with the emergence of the more contagious and ...
In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Since then, RSV therapies have garnered renewed global attention. However, ...
A new method for quickly and accurately detecting nanoparticles and viruses marks a major advancement in virus detection technology, merging confocal fluorescence microscopy with microfluidic laminar ...
Diagnostic or polymerase chain reaction (PCR) tests are currently being used to diagnose patients with COVID-19. Antibody tests allow for more accurate tracking of the spread of the coronavirus.
In addition to PRRSV, the key reagents are available for African swine fever virus and porcine epidemic diarrhea virus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback